Tas Med Laboratories Indai Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda
- Net Worth -18.95%
- Total Assets -6.42%
About Tas Med Laboratories Indai
Tas Med Laboratories Indai Pvt Ltd (TMLIPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 April 2006 and has a history of 18 years and nine months. Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Harjinder Singh and Kuljeet Kaur serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230CH2006PTC029990
-
Company No.
029990
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Apr 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Tas Med Laboratories Indai?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harjinder Singh
|
Director | 04-Apr-2006 | Current |
|
Kuljeet Kaur
|
Director | 07-Feb-2012 | Current |
Financial Performance of Tas Med Laboratories Indai.
Tas Med Laboratories Indai Pvt Ltd, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tas Med Laboratories Indai?
Unlock access to Tas Med Laboratories Indai's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Tas Med (India) Private LimitedHarjinder Singh and Kuljeet Kaur are mutual person
-
Avenue Remedies India Private LimitedHarjinder Singh and Kuljeet Kaur are mutual person
-
Ashchem Organics Private Limited
Harjinder Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tas Med Laboratories Indai?
Unlock and access historical data on people associated with Tas Med Laboratories Indai, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tas Med Laboratories Indai, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tas Med Laboratories Indai's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
